Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Convaid and R82 to Expand Planned Giving to United Cerebral Palsy

Convaid Products,Inc.
Posted on: 10 Oct 16

PR Newswire

TORRANCE, Calif., Oct. 10, 2016

TORRANCE, Calif., Oct. 10, 2016 /PRNewswire-iReach/ -- Global prevalence of Cerebral Palsy ranges from 1.5 to more than 4 per 1,000 live births and is the most common motor disability in childhood. Convaid and R82 products are often prescribed for children living with Cerebral Palsy to facilitate mobility and daily living.

Photo - 

In support United Cerebral Palsy of Oregon and Southwestern Washington, Convaid and R82 will participate in this UCP affiliate's 17th Semi-Annual Family Support Conference on Cerebral Palsy & Developmental Disabilities to be held on October 21-22, 2016 at the Holiday Inn Portland Airport Hotel, located at 8439 NE Columbia Blvd, Portland, OR 97220.

The Portland-based affiliate has advanced independence, productivity and full citizenship of people living with Cerebral Palsy and other disabilities since 1955.

Convaid and R82 will participate in the two-day conference where Business Development Representative Rob Proracki will present a donation of a Convaid lightweight, compact folding pediatric wheelchair to a family designated by the affiliate. This year's theme is We Are Family and the keynote speaker is Lou Radja, a Congo native and an inspiring, positive international speaker. Click here for an advance view.

"We are committed to discovering new ways of helping them lead meaningful and fulfilling lives, that are full of personal choice and rich in community experiences and relationships. The alliance with Convaid and R82 is a prime example of how we partner with others in the Cerebral Palsy community to provide new avenues of information and access to products for members community members," said Susan Cushman, Family Support Director, UCP of Oregon and SW Washington.  

To advance education on Cerebral Palsy and solutions to specialized products, Convaid is hosting a series of no-fee webinars, the first which was held in September and is now available on demand by clicking here and two additional webinars later this month and in November.

Standing and Walking , to be held on Thursday, October 20, 2016; and, Use of Home Equipment, to be held on Thursday, November 17, 2016. Both webinars will start promptly at 9:30AM, presented by Convaid and R82 seating and mobility expert K. Missy Ball, MT, PT, ATP, and certified pediatric NDT. She is the former Acting Director of the Physical Therapy Department of Children's Hospital in New Orleans, where she co-directed the hospital's seating program for 10-years while also working with UCP's Seating Clinic.

The first webinar, Seating and Mobility, held last month, is available on demand. It defined Cerebral Palsy causes,  risks factors, classification and description of the different types of Cerebral Palsy while addressing specific seating and mobility issues.  It covered classifications based on type, bodily involvement and severity.  The Gross Motor Functional Classification Scale was discussed as a reference for Cerebral Palsy severity and equipment options. Specific clinical manifestations found in each type of cerebral palsy were explored in the context of seating and mobility options of Convaid and R82 products. You may click here to view.

For more information, prospective attendees may contact:

Throughout North America, Convaid and R82 market products in the following categories:

The Convaid and R82 brands offer pediatric products typically prescribed to individuals with mild to moderate involvement of the following conditions:  Cerebral Palsy, Down Syndrome, Duchene Muscular Dystrophy, Spinal Muscular Atrophy, Spina Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders, among others.

About Etac | The Etac Group offers a wide range of solutions for children and adults ranging from manual wheelchairs, advanced seating, patient transfer, bathing and toilet products. Sweden-based Etac markets their products under the Etac, Molift, Immedia, R82 and Convaid brands. Etac operates sales companies in Sweden, Norway, Denmark, Germany, the Netherlands, the United Kingdom, Australia and the United States with an extensive network of distributors in 40 other markets around the world.

About R82 | Based in Denmark, R82 develops and produces innovative aids and appliances for special need children and young adults. These are tailored to individual needs based on comprehensive product development and clinical input. R82 prides itself on a high caliber of quality of service and customer engagement.

About Convaid | Convaid, the company that invented the adaptive assisted wheelchair, has helped special needs children and their families live fuller, more productive lives since 1976. Convaid produces high-performance, easy-to-use and attractive mobility products for all stages of a young person's life, from infancy to young adulthood. Each product is custom-built to individual specifications to provide optimum comfort, safety and convenience. 

Together R82 and Convaid form the Etac Pediatric Group.


R82 website          

R82 Facebook      

Convaid Community Blog                   

Convaid Facebook             

Convaid website

Media Contact: Milena Rimassa, Convaid Products, Inc., 310-618-0111,

News distributed by PR Newswire iReach:

SOURCE Convaid Products, Inc.

PR Newswire

Last updated on: 10/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.